Search Results - "Merrigan MM"

Structural determinants of SlpA-mediated phage recognition in Clostridioides difficile.

Authors: Royer, Alexia L.M. Dion, Émeline Umansky, Andrew A. et al.

Source: PLoS Pathogens. 11/26/2025, Vol. 21 Issue 11, p1-28. 28p.

A sporulation signature protease is required for assembly of the spore surface layers, germination and host colonization in Clostridioides difficile.

Authors: Marini, Eleonora Olivença, Carmen Ramalhete, Sara et al.

Source: PLoS Pathogens. 11/13/2023, Vol. 19 Issue 11, p1-37. 37p.

PPAR-γ agonist mitigates intestinal barrier dysfunction and inflammation induced by Clostridioides difficile SlpA in vitro.

Authors: Noori, Maryam Azimirad, Masoumeh Ghorbaninejad, Mahsa et al.

Source: Scientific Reports. 12/30/2024, Vol. 14 Issue 1, p1-15. 15p.

A monoclonal antibody collection for C. difficile typing ?

Authors: Hunault, Lise England, Patrick Barbut, Frédéric et al.

Source: Gut Pathogens. 1/19/2024, Vol. 16 Issue 1, p1-9. 9p.

An intact S-layer is advantageous to Clostridioides difficile within the host.

Authors: Ormsby, Michael J. Vaz, Filipa Kirk, Joseph A. et al.

Source: PLoS Pathogens. 6/29/2023, Vol. 18 Issue 6, p1-26. 26p.

Surface layer protein A from hypervirulent Clostridioides difficile ribotypes induce significant changes in the gene expression of tight junctions and inflammatory response in human intestinal epithelial cells.

Authors: Noori, Maryam Azimirad, Masoumeh Eslami, Gita et al.

Source: BMC Microbiology. 10/27/2022, Vol. 22 Issue 1, p1-12. 12p.

Characterization of the virulence of three novel clade 2 Clostridioides (Clostridium) difficile strains and a two-year screening in animals and humans in Brazil.

Authors: Diniz, Amanda Nadia Moura, Loren Nery Fontoura Cruz, Diogo Soares Gonçalves et al.

Source: PLoS ONE. 8/26/2022, Vol. 17 Issue 8, p1-21. 21p.

Evaluating the antibacterial, antibiofilm, and anti-toxigenic effects of postbiotics from lactic acid bacteria on Clostridium difficile.

Authors: Ozma, Mahdi Asghari Hosseini, Hamideh Mahmoodzadeh Ataee, Mohammad Hossein et al.

Source: Iranian Journal of Microbiology. Aug2024, Vol. 16 Issue 4, p497-508. 12p.

Time-course transcriptomics reveals that amino acids catabolism plays a key role in toxinogenesis and morphology in Clostridium tetani.

Authors: Orellana, Camila A. Zaragoza, Nicolas E. Licona-Cassani, Cuauhtemoc et al.

Source: Journal of Industrial Microbiology & Biotechnology. 2020, Vol. 47 Issue 12, p1059-1073. 15p.

Pathogenicity and virulence of Clostridioides difficile.

Authors: Buddle, Jessica E. Fagan, Robert P.

Source: Virulence. Dec2023, Vol. 14 Issue 1, p1-25. 25p.

Probiotics: insights and new opportunities for Clostridioides difficile intervention.

Authors: Pal, Rusha Athamneh, Ahmad I. M. Deshpande, Riddhi et al.

Source: Critical Reviews in Microbiology. May2023, Vol. 49 Issue 3, p414-434. 21p.

Diagnosis of Clostridium difficile infection by toxigenic culture and PCR assay.

Authors: Mirzaei, Elnaze Zare Rajabnia, Mahdi Sadeghi, Farzin et al.

Source: Iranian Journal of Microbiology. Oct2018, Vol. 10 Issue 5, p287-293. 7p.

Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin.

Authors: Kuehne, Sarah A Dempster, Andrew W Collery, Mark M et al.

Source: Journal of Deaf Studies & Deaf Education. Apr2018, Vol. 23 Issue 2, p973-980. 8p.

Subject Terms: Alleles, Clostridioides difficile, Clostridium diseases, Disease susceptibility, Erythromycin, Genetic polymorphisms, Microbial sensitivity tests, Genetic mutation, Transferases, Microbial virulence, Sequence analysis, In vitro studies, Fidaxomicin, In vivo studies, Pharmacodynamics, Therapeutics

Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case-control study.

Authors: Kim, Min Hyung Kim, Yong Chan Kim, Jung Lim et al.

Source: BMC Infectious Diseases. 1/29/2022, Vol. 22 Issue 1, p1-9. 9p.

Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.

Authors: Qiu, Hongyu Cassan, Robyn Johnstone, Darrell et al.

Source: PLoS ONE. 6/23/2016, Vol. 11 Issue 6, p1-21. 21p.

Extracellular DNA, cell surface proteins and c-di-GMP promote biofilm formation in Clostridioides difficile.

Authors: Dawson, Lisa F. Peltier, Johann Hall, Catherine L. et al.

Source: Scientific Reports. 2/5/2021, Vol. 11 Issue 1, p1-21. 21p.

Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina.

Authors: Goorhuis, A. Legaria, M. C. van den Berg, R. J. et al.

Source: Clinical Microbiology & Infection. Dec2009, Vol. 15 Issue 12, p1080-1086. 7p. 2 Diagrams, 2 Charts.

New multiplex PCR method for the detection of Clostridium difficile toxin A ( tcdA) and toxin B ( tcdB) and the binary toxin ( cdtA/ cdtB) genes applied to a Danish strain collection.

Authors: Persson, S. Torpdahl, M. Olsen, K. E. P.

Source: Clinical Microbiology & Infection. Nov2008, Vol. 14 Issue 11, p1057-1064. 8p. 1 Black and White Photograph, 2 Charts.

Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report.

Authors: Miner, Jonathan Gillan, M Monem Alex, Philip et al.

Source: BMC Gastroenterology. 2005, Vol. 5, p3-5. 5p. 1 Color Photograph.

Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain.

Authors: Skinner, Andrew M. Petrella, Laurica Siddiqui, Farida et al.

Source: Emerging Infectious Diseases. Feb2020, Vol. 26 Issue 2, p247-254. 8p.